These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M. Cancer Res; 1993 May 01; 53(9):2118-22. PubMed ID: 8481913 [Abstract] [Full Text] [Related]
10. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Auner HW, Sill H, Mulabecirovic A, Linkesch W, Krause R. Ann Hematol; 2002 Jul 01; 81(7):374-7. PubMed ID: 12185506 [Abstract] [Full Text] [Related]
11. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas. Dorfman DM, Shahsafaei A. Mod Pathol; 1996 Oct 01; 9(10):959-65. PubMed ID: 8902831 [Abstract] [Full Text] [Related]
12. [On the antipyretic action of indomethacin in Hodgkin's lymphogranuloma and in neoplasms]. Marcolongo R, Boggiano CA. Minerva Med; 1966 Sep 05; 57(71):2857-64. PubMed ID: 5917929 [No Abstract] [Full Text] [Related]
13. Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease. Armitage JO, Dick FR, Goeken JA, Foucar MK, Gingrich RD. Arch Intern Med; 1983 Mar 05; 143(3):445-50. PubMed ID: 6338848 [Abstract] [Full Text] [Related]
14. Mycosis fungoides associated with B-cell malignancies. Barzilai A, Trau H, David M, Feinmesser M, Bergman R, Shpiro D, Schiby G, Rosenblatt K, Or R, Hodak E. Br J Dermatol; 2006 Aug 05; 155(2):379-86. PubMed ID: 16882178 [Abstract] [Full Text] [Related]
15. Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. Greene MH, Wilson J. Natl Cancer Inst Monogr; 1985 Dec 05; 68():191-217. PubMed ID: 4088298 [Abstract] [Full Text] [Related]
18. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy. Proctor SJ, Taylor PR, Angus B, Wood K, Lennard AL, Lucraft H, Carey PJ, Stark A, Iqbal A, Haynes A, Russel N, Leonard RC, Culligan D, Conn J, Jackson GH. Eur J Haematol Suppl; 2001 Jul 05; 64():28-32. PubMed ID: 11486397 [Abstract] [Full Text] [Related]
19. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype. Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini MP, Stul M, Cassiman JJ, De Wolf-Peeters C. Am J Surg Pathol; 1992 Jan 05; 16(1):37-48. PubMed ID: 1728195 [Abstract] [Full Text] [Related]
20. How to use cancer chemotherapy. Dollinger MR. Am Fam Physician; 1971 Jun 05; 3(6):73-84. PubMed ID: 4325596 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]